Siga Pharm SRL
Siga Pharm reported total assets of 46,193 € at the end of the 2024 financial year (annual accounts filed with the NBB on 28 Aug 2025).
The score of Siga Pharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Siga Pharm's annual accounts
| 2024 | |
|---|---|
| Net result | 27,045 € |
| Equity | 29,045 € |
| Cash | 3,821 € |
| EBITDA | 37,893 € |
| Total assets | 46,193 € |
Filed annual accounts
- Year ended 31 Dec 2024filed on 28 Aug 2025
Siga Pharm's financial analysis
- Solvency62.9%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Siga Pharm
Siga Pharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0801.934.929
- VAT number
- BE0801934929
- Peppol
- Registered · 0208:0801934929 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 May 2023
- Registered office
- 1180 Uccle
- Latest accounts
- 2024 · filed on 28 Aug 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Siga Pharm (SRL) has been based in Uccle since 2023, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 27,045 € and equity of 29,045 €; its revenue is not published. Its solvency stands at 62.9%, above the median of its sector (37.8%).
Companies similar to Siga Pharm
Companies in the same business, of comparable size and area, outside its group.
- LEZY Invest Other business support service activities n.e.c. Woluwe-Saint-Lambert · balance sheet 88,748 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Vanfleteren Pieter Retail sale of pharmaceutical products Antwerp · balance sheet 52,894 €
- Helephar Retail sale of pharmaceutical products Wingene · balance sheet 55,332 €
- DEL Pharma Retail sale of pharmaceutical products Mons · balance sheet 36,943 €
- LEJV Retail sale of pharmaceutical products Bertrix · balance sheet 34,528 €
- Itipharma Ghyselen Retail sale of pharmaceutical products Soignies · balance sheet 61,934 €
- Tilosa Retail sale of pharmaceutical products Lokeren · balance sheet 70,195 €
Frequently asked questions about Siga Pharm
What is the revenue of Siga Pharm?
Siga Pharm files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Siga Pharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0801934929 for Siga Pharm, if the company is VAT-registered. Its company number (CBE) is 0801.934.929.
Where is the registered office of Siga Pharm?
According to the CBE register, the registered office of Siga Pharm is in 1180 Uccle.
What is the equity of Siga Pharm?
At the close of the 2024 financial year, the equity of Siga Pharm amounts to 29,045 €, a solvency of 62.9% of total assets.
Who manages Siga Pharm?
The register lists 1 active mandates at Siga Pharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Siga Pharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →